1. Gastric intestinal metaplasia: progress and remaining challenges

   • Qi-Yue Tong
   • Min-Jiao Pang
   • Zhi-Feng Miao

   Review 19 January 2024 Pages: 285 - 301

   

2. Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria

   • Makoto Naganuma
   • Naohiro Nakamura
   • The Japanese UC Study Group

   Original Article—Alimentary Tract 26 January 2024 Pages: 302 - 314

   

3. A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA

   • Takehisa Watanabe
   • Sanae Hayashi
   • Yasuhito Tanaka

   Original Article―Liver, Pancreas, and Biliary Tract 05 February 2024 Pages: 315 - 328

   

4. Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism

   • Isabel Cornejo-Pareja
   • Mohamed Reda Amiar
   • Francisco Jose Tinahones

   Original Article―Liver, Pancreas, and Biliary Tract Open access 24 January 2024 Pages: 329 - 341

   

5. Indoleamine 2,3-dioxygenase 1-mediated iron metabolism in macrophages contributes to lipid deposition in nonalcoholic steatohepatitis

   • Chaofeng Wu
   • Junjie Li
   • Lei Gao

   Original Article―Liver, Pancreas, and Biliary Tract 24 February 2024 Pages: 342 - 356

   

6. Assessing the side effects and resistance in H. pylori treatment: a discussion on minocycline versus tetracycline therapy

   • Tomohiro Kurokawa
   • Tomoharu Kurokawa

   Letter to the Editor 28 February 2024 Pages: 357 - 357

7. Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial

   • Yu Huang
   • Hong Lu

   Letter to the Editor 14 February 2024 Pages: 358 - 358

8. Role of combined aerobic and resistance exercise in liver cirrhosis

   • Tadashi Namisaki
   • Shinya Sato
   • Hitoshi Yoshiji

   Editorial 08 February 2024 Pages: 359 - 360